The "Consecutive Combined Test" - Using Double test from week 8 + 0 and Nuchal Translucency scan, for first trimester screening for Down syndrome

Prenatal Diagnosis

Volumn 26, Issue 12, 2006, Pages 1105-1109

  Schiøtt, Kirsten Marie ^a   Christiansen, Michael ^b   Petersen, Olav Bjørn ^a   Sørensen, Tina Lind ^b   Uldbjerg, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Down syndrome; Free hCG; Nuchal tranlucency; PAPP A; Prenatal screening

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; CONSECUTIVE COMBINED TEST; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY 21;

ADULT; ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; FETAL DISEASES; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 33845589234     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1487     Document Type: Article

References (19)

1. Avgidou K, et al. 2005. Prospective first-trimester screening for trisomi 21 in 30.564 pregnancies. Am J Obstet Gynecol 192: 1761-1767.
2. Benn PA. 2002. Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions (Review). Clin Chim Acta 324: 1-11.
3. Biasio P, et al. 1999. First-trimester screening for Down syndrome using nuchal translucency measurement with free B-hCG and PAPP-A between 10 and 13 weeks of gestation-the combined test. Prenat Diagn 19: 360-363.
4. Christiansen M, et al. 2001. Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals. Scand J Clin Lab Invest 61(3): 205-215.
5. Cicero S, et al. 2001. Absence of nasal bone in fetuses with trisomi 21 at 11-14 weeks of gestation: an observational study. Lancet 358: 1665-1667.
6. Cuckle HS, et al. 1987. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94(5): 387-402.
7. Cuckle HS, van Lith JMM. 1999. Appropriate biochemical parameters in first-trimester screening for Down syndrome. Prenat Diagn 19: 505-512.
8. Cuckle H. 2001. Time for a total shift to first-trimester screening for Down's syndrome. Lancet 358: 1658-1659.
9. Larsen SO, et al. 1998. Calculation of ROC curves in multidimensional likelihood ratio based screening with Down's syndrome as a special case. J Med Screen 5(2): 57-62.
10. Malone FD, et al. 2005. First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome. N Engl J Med 353(19): 2001-2011.
11. Nicolaides KH, et al. 2005. Multicenter study of first-trimester screening for trisomi 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound obstet Gynecol 25: 221-226.
12. Orlandi F, et al. 1997. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol 10: 381-386.
13. Schuchter K, et al. 2002. The first trimester "combined test" for the detection of Down syndrome pregnancies in 4939 unselected pregnancies. Prenat Diagn 22: 211-215.
14. Snijders RJM, et al. 1998. UK multicenter project on assessment of frisk of trisomy 21 by maternal age and nuchal translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
15. Spencer K. 2002. Accuracy of Down syndrome risks produced in a first-trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry. Prenat Diagn 22: 244-246.
16. Spencer K, et al. 2002. Temporal changes in maternal serum biochemical markers of trisomi 21 across the first and second trimester of pregnancy. Ann Clin Biochem 39: 567-576.
17. Wald NJ, et al. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10: 56-104.
18. Wapner R, et al. 2003. First-trimester screening for trisomies 21 and 18. N Engl J Med 349: 1405-1413.
19. Wøjdemann KR, et al. 2005. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women. Ultrasound Obstet Gynecol 25: 227-233.